TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
POA Pharma Scandinavia AB
Closing information (x1000 EUR)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
8,293
|
7,768
|
7,715 |
Financial expenses |
16
|
2
|
1 |
Earnings before taxes |
129
|
361
|
-244 |
EBITDA |
216
|
446
|
-183 |
Total assets |
4,595
|
3,737
|
3,589 |
Current assets |
4,395
|
3,505
|
3,268 |
Current liabilities |
2,235
|
1,300
|
1,318 |
Equity capital |
2,360
|
2,437
|
2,271 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
13
|
12
|
14 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
51.4%
|
65.2%
|
63.3% |
Turnover per employee |
638
|
647
|
551 |
Profit as a percentage of turnover |
1.6%
|
4.6%
|
-3.2% |
Return on assets (ROA) |
3.2%
|
9.7%
|
-6.8% |
Current ratio |
196.6%
|
269.6%
|
248.0% |
Return on equity (ROE) |
5.5%
|
14.8%
|
-10.7% |
Change turnover |
914
|
560
|
3,062 |
Change turnover % |
12%
|
8%
|
66% |
Chg. No. of employees |
1
|
-2
|
4 |
Chg. No. of employees % |
8%
|
-14%
|
40% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.